Recent publication honoured by the OTS

A recent publication utilising the precursor technology that underpins PepGen’s platform has been awarded ‘Paper of the Month‘ by the Board of Directors and the Scientific Advisory Council of the Oligonucleotide Therapeutics Society (OTS).

In addition, this publication is currently under consideration for the OTS Paper of the Year Award at the 2020 Annual Society Meeting.